Carillon Tower Advisers’s Inogen INGN Stock Holding History

Carillon Tower Advisers’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-139,746	Closed	-$34.1M	–	466
2018 Q3	$34.1M	Buy	+139,746	New	+$32.3M	0.24%	164

Other funds holding INGN

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Carillon Tower Advisers's INGN Position: Q4 2018 in Review

Carillon Tower Advisers sold out of Inogen (INGN) in Q4 2018, closing a stake of 139,746 shares — an estimated $34.1M sold.

Carillon Tower Advisers first reported a position in INGN in Q3 2018 and held it in 1 quarter. The position peaked at $34.1M in Q3 2018. 271 funds tracked by Wall St. Rank hold INGN as of Q4 2018.

Carillon Tower Advisers reported no remaining Inogen position as of Q4 2018 after selling out during the quarter.
Carillon Tower Advisers sold 139,746 Inogen shares in Q4 2018, an estimated $34.1M.
Carillon Tower Advisers first reported a position in Inogen in Q3 2018 and held it in 1 quarter.
Carillon Tower Advisers's Inogen position peaked at $34.1M in Q3 2018.
271 funds tracked by Wall St. Rank held Inogen as of Q4 2018.

Based on Carillon Tower Advisers's 13F filing for Q4 2018, filed 13 Feb 2019.